• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Education
  • Events
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs
  • Business Directory

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

Government asks regulator to approve supply of Oxford vaccine

28th November 2020 by PIP editor Leave a Comment

 

The government has formally asked the Medicines and Healthcare products Regulatory Agency to evaluate whether the supply of Oxford AstraZeneca vaccine can be authorised.

 

The move marks a significant first step in getting the vaccine approved for deployment, should it meet the regulator’s requirements.

 

The UK will be one of the first countries in the world to receive the vaccine, if authorised, with AstraZeneca expecting to have up to 4 million doses ready for the UK by the end of the year and 40 million by the end of March 2021.

 

The UK is the first country in the world to sign an agreement with Oxford University AstraZeneca, securing access to 100 million doses of the vaccine.

 

Earlier this week, the University of Oxford and AstraZeneca published their interim efficacy results, which indicated the vaccine was at least 70% effective in protecting individuals from COVID-19.

 

This rose to 90% effective when administered as half a dose, followed by a full dose – rather than 2 full doses.

 

Health and Social Care Secretary Matt Hancock said:

 

“We are working tirelessly to be in the best possible position to deploy a vaccine as soon as one is approved by the independent regulator, the MHRA.

 

“We have formally asked the regulator to assess the Oxford/AstraZeneca vaccine, to understand the data and determine whether it meets rigorous safety standards. This letter is an important step towards deploying a vaccine as quickly as safely possible.”

 

This circular is being shared under the Open Government Copyright licence.

 

 

Related

Next article  Lockdown methadone dispensing incident 'directly contributed to death'

Filed Under: News Tagged With: Vaccine

Register for our upcoming webinar and live Q&A

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Categories

PIP business directory

Letters to the editor

Letters to the editor

People can easily go to multiple pharmacies to buy codeine

How 56 community pharmacies helped to eradicate hepatitis C

Pharmacies should be allowed to supply rapid antibody tests

I failed by one mark and now can’t register as a pharmacist

More letters to the editor here...

Blogs

💊 PIP live pharmacy blog

Winter stresses must not ‘destabilise’ general practice

What is it like to depend on medicine to treat endometriosis?

Opinion

Why is pharmacy not integral to government mass vaccination plans?

Pharmacy Covid-19 vaccination involvement is a ‘no-brainer’

The great patient medication returns debacle

CPD Challenges

💊 CPD Challenge: How well do you understand pulmonary embolisms?

💊 CPD Challenge: Prescribing and dispensing clozapine

💊 CPD Challenge: Oral anticoagulants – Dabigatran

More CPD challenges here...

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.